Skip to content
Log in
Sponsored Artificial Intelligence: A Modern Approach, Global Edition Artificial Intelligence: A Modern Approach, Global Edition

Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model.

Semra Tasdurmazli Yasin Ali Çimen Ebru Kanımdan Fatma Bedia Karakaya Cimen Buse Findikli Mert Yılmaz E. Hekimoglu S. Ustunova M. Esrefoglu A. Koçyiğit Luís D R Melo Tulin Ozbek
Jul 2026 · European Journal of Clinical Microbiology and Infectious Diseases · 0 citations · 7 references
Medicine

TL;DR

Findings demonstrate the stability, safety, and therapeutic efficacy of bacteriophages EAS1 and EAS2, particularly EAS2, supporting phage therapy as a promising alternative approach for the treatment of MRSA infections.

DOI PubMed Semantic Scholar
View source

Similar papers

#protein folding Oct 2026

Design, Characterization, and Efficacy of ASEnd: A Novel Chimeric Endolysin for Targeting Methicillin-Resistant Staphylococcus aureus.

The emergence of antibiotic-resistant pathogens, particularly methicillin-resistant Staphylococcus aureus (MRSA), represents a major public health threat, with limited treatment options. Bacteriophage-derived endolysins and their engineered chimeric derivatives have attracted attention as alternative antibacterial agen...

Sarvenaz Janbaz, Amir Savardashtaki, Marziyeh Asadi et al. · 0 citations
Open access Sep 2026

Comprehensive characterization of Staphylococcus phage SAP_2 as a safe and effective biocontrol agent against methicillin-resistant Staphylococcus aureus

The potential of SAP_2 as a biocontrol candidate for controlling MRSA contamination in milk is supported and good biosafety and reduced bacterial burdens in MRSA-infected mice are exhibited.

Dong-Xin Ma, Shuai-Feng Gu, Yu-Qiang Zhang et al. · 0 citations
Open access Sep 2026

Genomic and functional characterization of novel therapeutic lytic bacteriophages targeting multidrug-resistant Enterobacter cloacae

Suggestion that in vitro evaluation of MMRP1 and MMRP4 are highly recommended to more deeper future experimental studies to combat MDR E. cloacae nosocomial infections supported by genomic foundation and eventually, the possibility to be suitable for phage-engineering applications in clinical settings is highlighted.

Mohammad S. A. Al-Obaidi, M. T. Al-Ouqaili, F. Al-Marzooq · 0 citations
Open access Jan 2026

Characterization and Therapeutic Potential of a Novel Bacteriophage Targeting Methicillin‐Resistant Staphylococcus aureus Biofilms on Medical Devices

This is the first biologically and genomically characterized S. aureus phage from Bangladesh with demonstrated activity against MDR MRSA biofilms, highlighting its potential as a promising candidate for controlling device‐associated MRSA infections.

Raphael Kabir Niloy, Shakhinur Islam Mondal, Nurnabi Azad Jewel et al. · 0 citations
Open access Oct 2026

Repurposing PFM01 as a novel antibacterial agent against Staphylococcus aureus

ABSTRACT Staphylococcus aureus infections pose a significant threat to global human health, particularly with the widespread transmission of methicillin-resistant S. aureus (MRSA) strains, which has created an urgent need for the development of new antimicrobial agents. PFM01 is an N-alkylated derivative of Mirin, an M...

Cong-Cong Li, Xuan-Cheng Huang, Ke-Wei Fan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.